New Head and Neck Cancer Findings from University of Rijeka Published (The Next Chapter in Cancer Diagnostics: Advances in HPV-Positive Head and Neck Cancer).

A recent report from the University of Rijeka in Croatia discusses the increasing prevalence of Human Papillomavirus (HPV)-associated head and neck squamous cell carcinoma (HNSCC), particularly oropharyngeal squamous cell carcinoma (OPSCC), worldwide. The report highlights the importance of accurately diagnosing HPV in HNSCC and personalizing treatment strategies. The combination of p16 immunohistochemistry (IHC) and polymerase chain reaction (PCR) is recommended for diagnosing HPV, with advanced techniques like next-generation sequencing (NGS) and RNA-based assays providing further insights. The report also explores various HPV detection techniques, biomarkers, and emerging technologies in the field. [Extracted from the article]